|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 38/25 | |
| C07K 14/575 |
| (11) | Patento numeris | 2152297 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 08760314.8 |
| Europos patento paraiškos padavimo data | 2008-05-30 | |
| (97) | Europos patento paraiškos paskelbimo data | 2010-02-17 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2015-04-29 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/EP2008/056727 |
| Data | 2008-05-30 |
| (87) | Numeris | WO 2008/145749 |
| Data | 2008-12-04 |
| (30) | Numeris | Data | Šalis |
| 941186 P | 2007-05-31 | US |
| (72) |
GHIGO, Ezio, IT
VAN DER LELY, Aart, Jan, NL
GRANATA, Riccarda, IT
|
| (73) |
Alizé Pharma SAS,
15, Chemin du Saquin, 69130 Ecully,
FR
|
| (54) | UNACYLATED GHRELIN AS THERAPEUTIC AGENT IN THE TREATMENT OF METABOLIC DISORDERS |
| UNACYLATED GHRELIN AS THERAPEUTIC AGENT IN THE TREATMENT OF METABOLIC DISORDERS |